Changxiang Yan
Capital Medical University(CN)Beijing Sanbo Brain Hospital(CN)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Pituitary Gland Disorders and Treatments, Meningioma and schwannoma management, RNA modifications and cancer, Protein Tyrosine Phosphatases
Most-Cited Works
- → Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis(2017)465 cited
- → Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies(2018)122 cited
- → The prognostic role of Ki-67/MIB-1 in meningioma(2020)109 cited
- → The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy(2018)103 cited
- → Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival(2017)97 cited
- → Prognostic role of pretreatment red blood cell distribution width in patients with cancer: A meta-analysis of 49 studies(2019)84 cited
- → Manganese-Doped Carbon Dots for Magnetic Resonance/Optical Dual-Modal Imaging of Tiny Brain Glioma(2018)79 cited
- → Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis(2013)78 cited
- → Preoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival(2018)73 cited
- → Alterations in the RTK/Ras/PI3K/AKT pathway serve as potential biomarkers for immunotherapy outcome of diffuse gliomas(2021)49 cited